Amelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapy

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chockalingam, S ^a   Ghosh, Siddhartha Sankar ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CD24 ANTIGEN; COLONY STIMULATING FACTOR 1; CYCLIN A2; CYCLIN E; FLUOROURACIL; HERMES ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; NOTCH1 RECEPTOR; PROTEIN MDM2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN U87MG; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOLECULAR CLONING; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUOROURACIL; GLIOBLASTOMA; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84896702528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083877     Document Type: Article

References (34)

1. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, et al. (1997) Biology and action of colony-stimulating factor-1. Mol Reprod Dev 46: 4-10. (Pubitemid 27021347)
2. Pollard JW, Hennighausen L (1994) Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci U S A 91: 9312-9316. (Pubitemid 24297904)
3. Michaelson MD, Bieri PL, Mehler MF, Xu H, Arezzo JC, et al. (1996) CSF-1 deficiency in mice results in abnormal brain development. Development 122: 2661-2672. (Pubitemid 26326499)
4. Douglass TG, Driggers L, Zhang JG, Hoa N, Delgado C, et al. (2008) Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies. Int Immunopharmacol 8: 1354-1376.
5. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612. (Pubitemid 43165918)
6. Curry JM, Eubank TD, Roberts RD, Wang Y, Pore N, et al. (2008) M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS One 3: e3405.
7. Jadus MR, Chen Y, Boldaji MT, Delgado C, Sanchez R, et al. (2003) Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins. Cancer Gene Ther 10: 411-420. (Pubitemid 36528785)
8. Hoa NT, Zhang JG, Delgado CL, Myers MP, Callahan LL, et al. (2007) Human monocytes kill M-CSF-expressing glioma cells by BK channel activation. Lab Invest 87: 115-129.
9. Kawakami Y, Nagai N, Ohama K, Zeki K, Yoshida Y, et al. (2000) Macrophage-colony stimulating factor inhibits the growth of human ovarian cancer cells in vitro. Eur J Cancer 36: 1991-1997.
10. Das AB, Loying P, Bose B (2012) Human recombinant Cripto-1 increases doubling time and reduces proliferation of HeLa cells independent of pro-proliferation pathways. Cancer Lett 318: 189-198.
11. Sharma S, Chockalingam S, Sanpui P, Chattopadhyay A, Ghosh SS (2013) Silver Nanoparticles Impregnated Alginate-Chitosan-Blended Nanocarrier Induces Apoptosis in Human Glioblastoma Cells. Adv Healthcare Mater. doi:10.1002/adhm.201300090.
12. Nakai E, Park K, Yawata T, Chihara T, Kumazawa A, et al. (2009) Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma. Cancer Invest 27: 901-908.
13. Bredel M, Zentner J (2002) Brain-tumour drug resistance: the bare essentials. The Lancet Oncology 3: 397-406. (Pubitemid 36958270)
14. Finkel E (2001) The mitochondrion: is it central to apoptosis? Science 292: 624-626.
15. Yue X, Favot P, Dunn TL, Cassady AI, Hume DA (1993) Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation. Mol Cell Biol 13: 3191-3201. (Pubitemid 23157257)
16. Zwaenepoel O, Tzenaki N, Vergetaki A, Makrigiannakis A, Vanhaesebroeck B, et al. (2012) Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110delta isoform of PI 3-kinase. FASEB J 26: 691-706.
17. Sethi N, Kang Y (2011) Notch signalling in cancer progression and bone metastasis. Br J Cancer 105: 1805-1810.
18. Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
19. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36: 1046-1069. (Pubitemid 38501557)
20. Bao B, Wang Z, Ali S, Kong D, Li Y, et al. (2011) Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 307: 26-36.
21. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. (Pubitemid 351636299)
22. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, et al. (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141: 583-594.
23. Dembinski JL, Krauss S (2009) Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis 26: 611-623.
24. Ahmed MA, Aleskandarany MA, Rakha EA, Moustafa RZ, Benhasouna A, et al. (2012) A CD44(-)/CD24(+) phenotype is a poor prognostic marker in early invasive breast cancer. Breast Cancer Res Treat 133: 979-995.
25. Zhang C, Li C, He F, Cai Y, Yang H (2011) Identification of CD44+CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol 137: 1679-1686.
26. Jaggupilli A, Elkord E (2012) Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin Dev Immunol 2012: 708036.
27. Deng J, Gao G, Wang L, Wang T, Yu J, et al. (2012) CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas. Journal of Biomedicine and Biotechnology 2012.
28. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284. (Pubitemid 40488633)
29. Drake KJ, Singhal J, Yadav S, Nadkar A, Pungaliya C, et al. (2007) RALBP1/RLIP76 mediates multidrug resistance. Int J Oncol 30: 139-144.
30. Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, et al. (2005) RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 6: 61.
31. Kacinski BM (1997) CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 46: 71-74.
32. Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, et al. (1995) The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1: 313-325.
33. Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML (1997) Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 3: 999-1007. (Pubitemid 27252950)
34. Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U, Okulczyk B, Kedra B, et al. (2007) Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 380: 208-212. (Pubitemid 46498063)